Dr Peters current work is focused on use of different antihypertensives, frailty and risk and benefit of treatment in the very elderly.
Between 2010 and 2012 Dr Peters was part of the core team setting up and developing the Imperial Clinical Trials Unit (ICTU). ICTU was launched in 2010 and is a fully UKCRC registered trials unit.
Prior to 2010 she led the multinational HYpertension in the Very Elderly Trial Cognitve function (HYVET-COG) study and co-ordinated the main Hypertension in the Very Elderly [HYVET] trial. HYVET was an Imperial sponsored multinational double blind RCT which was rated ‘Trial of the year’ by the Society for Clinical Trials and an exceptional landmark in medicine(F1000) in 2008. The HYVET trial results have changed global guidelines for the use of antihypertensive treatment in older adults (>=80 years).
Research interests include risk factors for dementia, particularly cardiovascular risk factors and potential interventions to ameliorate or prevent cognitive decline and dementia.
et al., 2018, Effect of SSRI and calcium channel blockers on depression symptoms and cognitive function in elderly persons treated for hypertension: three city cohort study., Int Psychogeriatr, Pages:1-10
Anstey KJ, Ashby-Mitchell K, Peters R, 2017, Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis., J Alzheimers Dis, Vol:56, Pages:215-228
et al., 2017, The Vascular Impairment of Cognition Classification Consensus Study, Alzheimers & Dementia, Vol:13, ISSN:1552-5260, Pages:624-633
et al., 2017, Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial, Blood Pressure, Vol:26, ISSN:0803-7051, Pages:109-114
et al., 2017, Joining forces to prevent dementia: The International Research Network On Dementia Prevention (IRNDP)., Int Psychogeriatr, Vol:29, Pages:1757-1760